Bluebird Bio Inc. sell Morgan Stanley
Start price
03.04.23
/
50%
€3.03
Target price
03.04.24
€2.76
Performance (%)
-64.27%
End price
04.04.24
€1.08
Summary
This prediction ended on 04.04.24 with a price of €1.08. Morgan_Stanley correctly predicted massive losses of -64.27% for Bluebird Bio Inc.. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% |
Comments by Morgan_Stanley for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Morgan Stanley from $4.00 to $3.00. They now have an "underweight" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten